Search Results for "poverty guidelines"
Displaying 1 - 20 of 303 results. 20 results shown per page. Page 1 of 16.
Early Changes in Waivered Clinicians and Utilization of Buprenorphine for Opioid Use Disorder After Implementation of the 2021 HHS Buprenorphine Practice Guidelines
Publication Date
In April 2021 the U.S. Department of Health and Human Services (HHS) issued revised Practice Guidelines for the Administration of Buprenorphine for Treating Opioid Use Disorder (Practice Guideline).
Meeting Substance Use and Social Service Needs in Communities of Color
Publication Date
In this brief, we highlight experiences and practices from substance use treatment providers and their human services partners when serving people of color. We selected providers that focused on serving people of color, and this study was not intended to assess outcomes or effectiveness of any of the practices highlighted.
Advancing Primary Prevention in Human Services: Key Considerations for Administrators and Practitioners
Publication Date
This brief presents considerations for program administrators and other practitioners around increasing the use of primary prevention in human services systems to shift from responding to families after they are in crisis to preventing the crisis before it occurs.
Advancing Primary Prevention in Human Services: Key Considerations for Policy Designers and Funding Partners
Publication Date
This brief provides key considerations for policy designers and funding partners—such as federal staff, technical experts, and philanthropic partners—on incorporating primary prevention into human services delivery.
Advancing Primary Prevention in Human Services: Opportunities for People with Lived Experience
Publication Date
This brief highlights a new way of delivering primary prevention services that promotes equity by relying on the guidance and leadership of people with lived experience. The policy designers and service providers behind prevention services should have lived experience and/or co-create these services with people who do.
Fetal Alcohol Spectrum Disorders Research Briefs
Publication Date
Fetal Alcohol Spectrum Disorders (FASD) is an umbrella term used to describe the range of disability that can result from prenatal alcohol exposure. FASD is an important public health and social issue associated with a large burden on society through the healthcare system, mental health and substance abuse system, foster care, criminal justice system, and long-term disability care services.
Advancing Primary Prevention in Human Services: Convening Findings
Publication Date
This brief highlights key themes and ideas from a Health and Human Services (HHS) Convening on Advancing Primary Prevention in Human Services in August 2022. With a particular focus on prevention of youth and family homelessness, the convening featured the perspectives of academic experts, program administrators, federal colleagues, and people with lived expertise.
Leading Practices to Advance Equity and Support of Underserved Communities throughout Health and Human Services Programs
Publication Date
CDC — Gonorrhea Link: Request for Correction (RFC)
Publication Date
Requestor: Organizational Affiliation: Contractor, Division of STD Prevention Type of Disseminated Information: Website Date of request: 1/8/2003 Description of Information:
FDA — Campylobacter Risk Assessment: HHS Response to Rfc
Publication Date
March 22, 2003 Kent D. McClure, DVM, JD General Counsel Animal Health Institute 1325 G Street, NW, Suite 700 Washington, D.C. 20005-3104 Dear Dr. McClure:
FDA — Campylobacter Risk Assessment: HHS Response to Rfr
Publication Date
September 16, 2003 Kent D. McClure, D.V.M., J.D. General Counsel Animal Health Institute1324 G Street, N.W. Suite 700Washington, D.C. 20005 Re: Appeal of Request for Correction of Information Dear Dr. McClure:
FDA — Campylobacter Risk Assessment: Request for Reconsideration (RFR)
Publication Date
April 16, 2003 VIA HAND DELIVERY and E-MAIL (w/o Attachments) Office of the Ombudsman Food and Drug Administration 5600 Fishers Lane Room 14B03, HF-7 Rockville, MD 20857 Re: INFORMATION QUALITY APPEAL Dear Sir/Madame:
NIH — Smokeless Tobacco: HHS Response to Rfc
Publication Date
June 29, 2004 Mr. Ken Boehm National Legal and Policy Center 107 Park Washington Court Falls Church, VA 22046 Dear Mr. Boehm:
SAMHSA — Smokeless Tobacco Risks: Request for Correction (RFC)
Publication Date
Date: December 12, 2005 Mr. Mark Weber Director, Office of Communications Substance Abuse and Mental Health Services Administration Re: Request for Correction of Erroneous Information Under the Data Quality Act Dear Mr. Weber:
SAMHSA — Smokeless Tobacco Risks: HHS Response to Rfc
Publication Date
Date: May 10, 2006 To: Kenneth F. Boehm, Chairman National Legal and Policy Center Dear Mr. Boehm: Thank you for your "Request for Correction of Information" under the Substance Abuse and Mental Health Administration Guidelines for Ensuring the Quality of Information Disseminated to the Public. This office received your request on December 22, 2005.
SAMHSA — Smokeless Tobacco Risks: Interim Response
Publication Date
Date: March 2, 2006 To: Kenneth F. Boehm, Chairman National Legal and Policy Center Dear Mr. Boehm:
NIH — Smokeless Tobacco Ingredients: Interim Response
Publication Date
From: Info Quality (NIH/OD) [mailto:InfoQuality@OD.NIH.GOV] Sent: Thursday, June 01, 2006 6:46 PM To: Roerty, Gerry (RIC) Subject: Request for Reconsideration Submitted by Swedish Match Regarding Smokeless Tobacco Dear Mr. Roerty:
FDA — Menthol Cigarette Presentations: Interim Response, November 8, 2010
Publication Date
November 8, 2010 Mr. Jim Tozzi Center for Regulatory Effectiveness (CRE) Suite 500 1601 Connecticut Avenue, NW Washington, DC 20009 Re: Request for Correction pursuant to the Data Quality Act: FDA Studies on Menthol and Cigarettes Dear Mr. Tozzi:
FDA — Menthol Cigarette Presentations: Interim Response, March 17, 2011
Publication Date
March 17, 2011 Mr. Jim TozziCenter for Regulatory Effectiveness (CRE)Suite 500 1601 Connecticut Avenue, NW Washington, DC 20009 Re: Request for Correction pursuant to the Data Quality Act: FDA Studies on Menthol and Cigarettes Dear Mr. Tozzi:
FDA — Menthol Cigarette Presentations: Interim Response, January 14, 2011
Publication Date
January 14, 2011 Mr. Jim TozziCenter for Regulatory Effectiveness (CRE)Suite 500 1601 Connecticut Avenue, NW Washington, DC 20009 Re: Request for Correction pursuant to the Data Quality Act: FDA Studies on Menthol and Cigarettes Dear Mr. Tozzi: